Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. (Nasdaq: PWUP) is the operating entity formed through the business combination of Power Up Acquisition Corp, a blank-check company that targeted the life sciences and biopharmaceutical sector. The company filed an 8-K current report with the Securities and Exchange Commission on November 5, 2025, under accession number 0001493152-25-020891, continuing its public-company disclosure cycle following the de-SPAC transaction. Power Up Acquisition Corp completed its initial public offering in 2021, bringing the vehicle to market with a focus on biopharma deal-making. For full filing histories, deal timelines, and real-time SPAC analytics on PWUP and hundreds of other de-SPAC names, sign up for full data access at SpacDesk.